Who has invested in Graphite Bio?

Versant Ventures, Samsara BioCapital are named among the investors backing Graphite Bio.

Graphite Bio Funding: $45M Raised, Series A (2021)

Graphite Bio funding overview

Graphite Bio is based in South San Francisco, Country (or null). Graphite Bio has raised $45M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2021. The round record for Graphite Bio runs through 2021; nothing later has been disclosed. Investors on record include Versant Ventures, Samsara BioCapital. 2 distinct backers are named across the disclosed rounds.

Graphite Bio at a glance

Total raised: $45M
Latest round: Series A
Latest round date: March 2021
Headquarters: South San Francisco, Country (or null)
Notable investors: Versant Ventures, Samsara BioCapital

Frequently asked about Graphite Bio funding

How much has Graphite Bio raised?: Graphite Bio has raised $45M in total disclosed funding across the rounds on record.
Who has invested in Graphite Bio?: Versant Ventures, Samsara BioCapital are named among the investors backing Graphite Bio.
What was the latest Graphite Bio funding round?: The most recent disclosed round is a Series A, announced in March 2021.
Where is Graphite Bio based?: Graphite Bio is based in South San Francisco, Country (or null).
When did Graphite Bio last raise?: The last disclosed Graphite Bio round closed in March 2021 at Series A.

Graphite Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in South San Francisco below to benchmark round size and investor mix.

Graphite Bio Funding: $45M Raised, Series A (2021)

Graphite Bio funding overview

Graphite Bio at a glance

Frequently asked about Graphite Bio funding

Companies related to Graphite Bio (36)

Browse related funding lists (4)